Clinical Trial Update: Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase II study compares stereotactic body radiotherapy (SBRT) with conventional radiotherapy in patients with oligometastatic non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: NSCLC | Phase 2 | Status: UNKNOWN